PAPAVERINE DISPOSITION IN CARDIAC-SURGERY PATIENTS AND THE EFFECT OF CARDIOPULMONARY BYPASS

被引:13
作者
KRAMER, WG [1 ]
ROMAGNOLI, A [1 ]
机构
[1] TEXAS HEART INST,DEPT CARDIOVASC ANESTHESIOL,HOUSTON,TX 77025
关键词
D O I
10.1007/BF00544033
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:127 / 130
页数:4
相关论文
共 14 条
[1]  
AALTONEN L, 1982, ACTA PHARMACOL TOX, V51, P126
[2]  
BELPAIRE FM, 1978, XENOBIOTICA, V178, P297
[3]   ESTRIP, A BASIC COMPUTER-PROGRAM FOR OBTAINING INITIAL POLYEXPONENTIAL PARAMETER ESTIMATES [J].
BROWN, RD ;
MANNO, JE .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (12) :1687-1691
[4]   CORONARY-ARTERY SPASM IMMEDIATELY AFTER MYOCARDIAL REVASCULARIZATION - RECOGNITION AND MANAGEMENT [J].
BUXTON, AE ;
GOLDBERG, S ;
HARKEN, A ;
HIRSHFELD, J ;
KASTOR, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (21) :1249-1253
[5]  
GARRETT ER, 1978, INT J CLIN PHARM BI, V16, P193
[6]   EFFECT OF CARDIOPULMONARY BYPASS ON THE PHARMACOKINETICS OF DRUGS [J].
HOLLEY, FO ;
PONGANIS, KV ;
STANSKI, DR .
CLINICAL PHARMACOKINETICS, 1982, 7 (03) :234-251
[7]  
KOSKA AJ, 1981, CARDIOVASC DIS, V8, P405
[8]   EFFECT OF CARDIOPULMONARY BYPASS ON FENTANYL DISTRIBUTION AND ELIMINATION [J].
KOSKA, AJ ;
ROMAGNOLI, A ;
KRAMER, WG .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (01) :100-105
[9]  
KOSKA AJ, 1981, CARDIOVASC DIS B TEX, V8, P467
[10]  
METZLER CM, 1974, BIOMETRICS, V30, P562